SCHEMBL5175474

SCHEMBL5175474

CCCOCC(C)c1ccccc1Oc1ncccc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 2/20 0.38
SLC6A2 P23975 3/20 0.36
P2RY1 P47900 3/20 0.35
P2RX3 P56373 1/20 0.34
P2RX2 Q9UBL9 1/20 0.34
NISCH Q9Y2I1 1/20 0.34
PDE5A O76074 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
P2RY2 P41231 1/20 0.33
P2RY14 Q15391 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175228 0.81 ALDH1A1 (0.58) ALDH1A1MEN1POLBKMT2AKDM4E
SCHEMBL12680868 0.79 P2RX3 (0.52) ALDH1A1SLC6A2P2RY1P2RX3P2RX2
SCHEMBL5175471 0.75 ALDH1A1 (0.40) CYP1A2CYP2C9CYP2C19ALDH1A1SLC6A2
SCHEMBL5175478 0.73 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19ALDH1A1SLC6A2
SCHEMBL27533292 0.72 HTT (0.48) CYP1A2CYP2C9CYP2C19ALDH1A1NISCH
SCHEMBL3257799 0.72 P2RY1 (0.45) CYP1A2CYP2C9CYP2C19ALDH1A1P2RY1
SCHEMBL1936652 0.70 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1PDE5A
SCHEMBL9482190 0.70 ALDH1A1 (0.44) CYP1A2CYP2C9CYP2C19ALDH1A1SLC6A2
SCHEMBL1340918 0.68 ALDH1A1 (0.53) CYP1A2CYP2C19ALDH1A1SLC6A2MEN1
SCHEMBL29977462 0.67 ALDH1A1 (0.50) ALDH1A1SLC6A2SLC6A4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751113-A1 UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS Bristol-Myers Squibb Pharma Company (US) 2007-02-14 EP disclosed
WO-2005113511-A1 UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-01 WO disclosed